Pathogenic Mutations Shift the Equilibria of α‐Synuclein Single Molecules towards Structured Conformers |
| |
Authors: | Marco Brucale Dr. Massimo Sandal Dr. Selena Di Maio Aldo Rampioni Dr. Isabella Tessari Dr. Laura Tosatto Marco Bisaglia Dr. Luigi Bubacco Prof. Bruno Samorì Prof. |
| |
Affiliation: | 1. Department of Biochemistry, University of Bologna via Irnerio 48, 40126 Bologna (Italy), Fax: (+39)?051‐2094387;2. Department of Biology, University of Padova via U. Bassi 58/B, 35121 Padova (Italy) |
| |
Abstract: | α‐synuclein (α‐Syn) is an abundant brain protein whose mutations have been linked to early‐onset Parkinson's disease (PD). We recently demonstrated, by means of a single‐molecule force spectroscopy (SMFS) methodology, that the conformational equilibrium of monomeric wild‐type (WT) α‐Syn shifts toward β‐containing structures in several unrelated conditions linked to PD pathogenicity. Herein, we follow the same methodology previously employed for WT α‐Syn to characterize the conformational heterogeneity of pathological α‐Syn mutants A30P, A53T, and E46K. Contrary to the bulk ensemble‐averaged spectroscopies so far employed to this end by different authors, our single‐molecule methodology monitored marked differences in the conformational behaviors of the mutants with respect to the WT sequence. We found that all the mutants have a much higher propensity than the WT to adopt a monomeric compact conformation that is compatible with the acquiring of β structure. Mutants A30P and A53T show a similar conformational equilibrium that is significantly different from that of E46K. Another class of conformations, stabilized by mechanically weak interactions (MWI), shows a higher variety in the mutants than in the WT protein. In the A30P mutant these interactions are relatively stronger, and therefore the corresponding conformations are possibly more structured. The more structured and globular conformations of the mutants can explain their higher propensity to aggregate with respect to the WT. |
| |
Keywords: | AFM aggregation alpha‐synuclein Parkinson's disease single‐molecule studies |
|
|